DR. THEOFANIS MITSINIKOS D.O. NPI 1467624064

NPI Information

  • NPI: 1467624064
  • Provider Name: DR. THEOFANIS MITSINIKOS, D.O.
  • Classification: Internal Medicine - 207RE0101X
  • Specialization: Endocrinology, Diabetes & Metabolism
  • Entity Type: Individual
  • PECOS Registration: Yes
  • CLIA Number: 33D0887830
  • Address: 2500 NESCONSET HWY
    BLDG 3C
    STONY BROOK, NY
    ZIP 11790
  • Phone: (631) 751-2400

Map and Directions

Get Directions

NPI Details

DR. Theofanis Mitsinikos, D.O. is an endocrinology and diabetes and metabolism internal medicine in Stony Brook, NY with 22 years of experience. The provider is an internist who concentrates on disorders of the internal (endocrine) glands such as the thyroid and adrenal glands. This specialist also deals with disorders such as diabetes, metabolic and nutritional disorders, obesity, pituitary diseases and menstrual and sexual problems. DR. Theofanis Mitsinikos, D.O. NPI is 1467624064. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: NEW YORK COLLEGE OF OSTEO MEDICINE OF NEW YORK INSTITUTE OF TECHNOLOGY
Graduation Year:2003

The provider's business location address is:

2500 NESCONSET HWY
BLDG 3C
STONY BROOK, NY
ZIP 11790-555
Phone: (631) 751-2400
Fax: (631) 751-8323

The NPI 1467624064 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The CLIA number assigned to this NPI record is 33D0887830 - physician office with a certificate type of Certificate of Compliance.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Thyroid hormone, t3 measurement, free (HCPCS:84481)
  • Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
  • Thyroxine (thyroid chemical), free (HCPCS:84439)
  • Hemoglobin a1c level (HCPCS:83036)
  • Phosphate level (HCPCS:84100)
  • Magnesium level (HCPCS:83735)
  • Uric acid level, blood (HCPCS:84550)
  • Glutamyltransferase (liver enzyme) level (HCPCS:82977)
  • Liver function blood test panel (HCPCS:80076)
  • Blood creatinine level (HCPCS:82565)
  • Blood glucose (sugar) level (HCPCS:82947)
  • Calcium level, total (HCPCS:82310)
  • Urea nitrogen level to assess kidney function, quantitative (HCPCS:84520)
  • Vitamin d-3 level (HCPCS:82306)
  • Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report (HCPCS:95251)
  • Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
  • Folic acid level, serum (HCPCS:82746)
  • Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
  • Homocysteine (amino acid) level (HCPCS:83090)
  • Ldl cholesterol level (HCPCS:83721)
  • Measurement c-reactive protein for detection of infection or inflammation, high sensitivity (HCPCS:86141)
  • Urine microalbumin (protein) level (HCPCS:82043)
  • Creatinine level to test for kidney function or muscle injury (HCPCS:82570)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment (HCPCS:95250)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Ultrasound scan of head and neck soft tissue (HCPCS:76536)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Fine needle aspiration biopsy using ultrasound guidance, first growth (HCPCS:10005)
  • Ultrasonic guidance for needle placement (HCPCS:76942)
  • Blood glucose (sugar) measurement using reagent strip (HCPCS:82948)
  • Fine needle aspiration biopsy using ultrasound guidance, each additional growth (HCPCS:10006)

The enumeration date for this NPI number is 3/24/2008 and was last updated on 1/13/2011.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RE0101XInternal MedicineEndocrinology, Diabetes & Metabolism235458NEW YORKYes

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 3/30/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.